PATENT CLAIM ANALYSIS

Application Number: 16124558
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["424", "178100"]

Abstract:
Described herein are methods and compositions relating to anti-Chi3L1 antibodies, antibody reagents, and antigen-binding fragments thereof which display superior properties, e.g., high sensitivity, high specificity, high binding affinity, neutralization activity ex vivo and in vivo (e.g., blocks Chi3L1-induced MAPK and AKT signaling). Methods of treatment, e.g., of treating cancer, obesity, and/or asthma by administering the compounds described herein are also provided.

Claim (Index 6):
The antibody, antibody reagent, antigen-binding portion thereof, or CAR of  claim 1 , comprising a light chain sequence having the amino acid sequence of SEQ ID NO: 38.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 97.0
- Lexical Diversity: 1.42593
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15146294', '15143162', '15361936', '13483809', '15245853']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7410134521617621
- 35 USC 102 Novelty (BERT): 0.5204339041263955
- Combined Prediction Score: 0.7189554973582254
- Mean Citation Score: 326.489688
- Max Citation Score: 329.79126
- Similarity Product: 243.23680351123096

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test